AI Can Write a Virus's Genome. It Still Can't Read One
Scientists mutated every letter of the ΦX174 phage genome and measured the result. Top AI models predicted it only moderately well, a reality check for AI biology.
AI Beat the Lab at Antibody Design, But Just Once
The first blinded, wet-lab-validated benchmark for AI antibody design just landed in Nature Biotechnology. Here is what the models got right, and wrong.
A Nobel Laureate's AI Just Tried to Simulate a Whole Human Cell
GenBio AI's AIDO Cell is a 'world model' that simulates a human cell across scales, from DNA to shape. Here's what it does, why it matters, and what still needs proving.
AI Discovered a Novel Drug Target; and Pharma Bought It
Genentech validated the first AI-discovered neuroscience drug target from its $12B Recursion partnership. A proof point the AI-drug discovery field needed.
Evolution as Training Data: How Biohub's Open Protein World Model Is Rewiring Drug Discovery
Biohub's open-source ESM models learned the rules of protein biology from evolution alone — and designed working drug binders in days. Here's what the release means, and where it falls short.
AI Drug Discovery's Moment of Truth: A $2.75B Bet, Zero Approvals, and the Drug That Could Change Both
Eli Lilly just wagered up to $2.75 billion on AI-designed medicines, yet not one AI-discovered drug has full FDA approval. Here's why 2026 is the year the field finally gets tested against clinical reality.
The First AI-Designed Drug Just Entered Phase III. Here's What That Actually Proves.
Insilico Medicine has pushed rentosertib, a drug whose target and molecule were both generated by AI, into a pivotal Phase III trial. It's the clearest test yet of whether AI drug discovery can produce medicines that work, not just headlines.
Ebola's 100-Day Test: The Bundibugyo Vaccine Sprint
The Bundibugyo Ebola outbreak is now the largest in DRC history. With no licensed vaccine, three candidates have reached human trials in weeks — a real-world stress test of the 100 Days Mission, AI-assisted drug discovery and outbreak modelling.